shikimic acid has been researched along with Koch's Disease in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (10.00) | 29.6817 |
| 2010's | 4 (40.00) | 24.3611 |
| 2020's | 5 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Basso, LA; Canduri, F; de Azevedo, WF; de Oliveira, JS; Dias, MV; Palma, MS; Pereira, JH; Santos, DS | 1 |
| Chhabhaiya, H; Dadlani, VG; Somani, RR; Tripathi, PK | 1 |
| Calderón, AI; Hobrath, JV; Reeve, N; Reynolds, RC; Simithy, J | 1 |
| Calderón, AI; Gill, G; Goodwin, DC; Simithy, J; Wang, Y | 1 |
| Baker, EN; Hutton, RD; Jiao, W; Parker, EJ; Reichau, S; Walker, SR | 1 |
| Abell, C; Blundell, TL; Dias, MV; Howard, NI; Korb, O; Schmidt, MF | 1 |
| Abbadi, BL; Basso, LA; Bizarro, CV; Borsoi, AF; de Matos Czeczot, A; de Souza, EV; Freitas de Freitas, T; Hopf, FSM; Machado, P; Perelló, MA; Roth, CD; Timmers, LFSM | 1 |
| Khan, IA; Rajput, VS; Runthala, A | 1 |
| Dahmer, BR; Ethur, EM; Timmers, LFSM | 1 |
| Aoki, S; Hori, C; Kawamoto, S; Okubo, S; Taniguchi, H | 1 |
1 review(s) available for shikimic acid and Koch's Disease
| Article | Year |
|---|---|
Shikimate Kinase Inhibitors: An Update on Promising Strategy against
Topics: Animals; Antitubercular Agents; Enzyme Inhibitors; Humans; Mammals; Mycobacterium tuberculosis; Tuberculosis | 2023 |
9 other study(ies) available for shikimic acid and Koch's Disease
| Article | Year |
|---|---|
Structure of shikimate kinase from Mycobacterium tuberculosis reveals the binding of shikimic acid.
Topics: Adenosine Diphosphate; Amino Acid Sequence; Arginine; Binding Sites; Catalysis; Chlorides; Chlorine; Cloning, Molecular; Crystallography, X-Ray; Glutamic Acid; Humans; Hydrogen Bonding; Ions; Kinetics; Magnesium; Models, Molecular; Molecular Sequence Data; Mycobacterium tuberculosis; Phosphotransferases (Alcohol Group Acceptor); Protein Binding; Protein Conformation; Protein Structure, Secondary; Shikimic Acid; Substrate Specificity; Tuberculosis | 2004 |
Synthesis, molecular docking, and biological evaluation of novel 1,2,4-triazole-isatin derivatives as potential Mycobacterium tuberculosis shikimate kinase inhibitors.
Topics: Antitubercular Agents; HEK293 Cells; Humans; Isatin; Microbial Sensitivity Tests; Molecular Docking Simulation; Mycobacterium tuberculosis; Phosphotransferases (Alcohol Group Acceptor); Shikimic Acid; Structure-Activity Relationship; Triazoles; Tuberculosis | 2022 |
Identification of shikimate kinase inhibitors among anti-Mycobacterium tuberculosis compounds by LC-MS.
Topics: Antitubercular Agents; Chromatography, Liquid; Drug Design; Drug Resistance, Microbial; Enzyme Inhibitors; Female; Humans; Hydrolases; Male; Mass Spectrometry; Molecular Structure; Mycobacterium tuberculosis; Phosphotransferases (Alcohol Group Acceptor); Shikimic Acid; Signal Transduction; Tuberculosis | 2014 |
Development of an ESI-LC-MS-based assay for kinetic evaluation of Mycobacterium tuberculosis shikimate kinase activity and inhibition.
Topics: Antitubercular Agents; Chromatography, Liquid; Enzyme Assays; Humans; Mycobacterium tuberculosis; Phosphotransferases (Alcohol Group Acceptor); Protein Kinase Inhibitors; Shikimic Acid; Spectrometry, Mass, Electrospray Ionization; Tuberculosis | 2015 |
Potent inhibitors of a shikimate pathway enzyme from Mycobacterium tuberculosis: combining mechanism- and modeling-based design.
Topics: Alcohol Oxidoreductases; Bacterial Proteins; Crystallography, X-Ray; Drug Design; Enzyme Inhibitors; Models, Molecular; Mycobacterium tuberculosis; Protein Structure, Tertiary; Shikimic Acid; Structure-Activity Relationship; Tuberculosis | 2011 |
Discovery of Schaeffer's acid analogues as lead structures of mycobacterium tuberculosis type II dehydroquinase using a rational drug design approach.
Topics: Antitubercular Agents; Catalytic Domain; Drug Design; Humans; Hydro-Lyases; Models, Molecular; Mycobacterium tuberculosis; Shikimic Acid; Structure-Activity Relationship; Tuberculosis | 2013 |
Identification of potential inhibitors of Mycobacterium tuberculosis shikimate kinase: molecular docking, in silico toxicity and in vitro experiments.
Topics: Antitubercular Agents; Humans; Molecular Docking Simulation; Mycobacterium tuberculosis; Tuberculosis | 2023 |
Discovery of new inhibitors of Mycobacterium tuberculosis EPSP synthase - A computational study.
Topics: 3-Phosphoshikimate 1-Carboxyvinyltransferase; Antitubercular Agents; Humans; Ligands; Molecular Docking Simulation; Molecular Dynamics Simulation; Mycobacterium tuberculosis; Ribavirin; Tuberculosis | 2023 |
Identification of novel antimicrobial compounds targeting Mycobacterium tuberculosis shikimate kinase using in silico hierarchical structure-based drug screening.
Topics: Animals; Anti-Infective Agents; Antitubercular Agents; Drug Evaluation, Preclinical; Mammals; Molecular Docking Simulation; Mycobacterium tuberculosis; Tuberculosis | 2023 |